Neurovascular headache and a midbrain vascular malformation: Evidence for a role of the brainstem in chronic migraine

Cephalalgia

Volumn 22, Issue 2, 2002, Pages 107-111

  Goadsby, P J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brainstem; Central neurogenic; Midbrain; Migraine

Indexed keywords

ADULT; ARTICLE; BRAIN STEM; CASE REPORT; CEREBROVASCULAR MALFORMATION; FEMALE; HUMAN; MESENCEPHALON; MIGRAINE; PATHOPHYSIOLOGY; PERIAQUEDUCTAL GRAY MATTER; POSITRON EMISSION TOMOGRAPHY; TENSION HEADACHE;

BLOOD VESSELS; BRAIN NEOPLASMS; BRAIN STEM; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; FEMALE; HEMANGIOMA, CAVERNOUS; HUMANS; MESENCEPHALON; MIDDLE AGED; MIGRAINE DISORDERS;

EID: 0036260965     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2002.00323.x     Document Type: Article

References (44)

1. Prevalence of migraine headache in the United States: Relation to age, income, race and other sociodemographic factors
2. The global burden of disease study - Implications for neurology
3. Migraine and reduced work performance: A population-based diary study
4. Serotonin and migraine
5. Sumatriptan: A receptor-targeted treatment for migraine
6. Headache
7. Pathophysiology of the migraine aura. The spreading depression theory
8. Brain stem activation in spontaneous human migraine attacks
9. Brainstem activation specific to migraine headache
10. Classification of daily and near-daily headaches: A field study of revised IHS criteria
11. Diseases of the nervous system
12. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
13. Prevalence of frequent headache in a population sample
14. Epidemiology of chronic daily headache in the general population
15. Sumatriptan for the range of headaches in migraine sufferers: Results of the Spectrum study
16. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache
17. Headache may arise from perturbation of brain
18. Headache secondary to deep brain implantation
19. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area
20. Periaqueductal grey matter dysfunction in migraine. Cause or the burden of illness?
21. Neural processing of craniovascular pain: A synthesis of the central structures involved in migraine
22. Experimental cranial pain elicited by capsaicin: A PET-study
23. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography
24. Hypothalamic activation in cluster headache attacks
25. The trigeminovascular system in humans. Pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation
26. Functional MRI in spontaneous attacks of SUNCT. Short-lasting neuralgiform headache with conjunctival injection and tearing
27. The periaqueductal gray matter modulates trigeminovascular input: A role in migraine?
28. Spinal projections from periaqueductal grey and dorsal raphe in the rat, cat and monkey
29. Stimulation of the periaqueductal gray matter of the rat produces preferential ipsilateral antinociception
30. The location of brainstem neurons which project bilaterally to the spinal trigeminal nuclei as demonstrated by double flourescent retrograde tracer technique
31. The anatomy of brain stem pathways to the spinal cord in cat. A labelled amino acid tracing study
32. On the functional anatomy of migraine
33. An association between migraine and cutaneous allodynia
34. Evidence for a central component of post-injury pain hypersensitivity
35. 2+ channel gene CACNLA4
36. Migraine
37. P/Q-type calcium channel blockade in the PAG facilitates trigeminal nociception: A functional genetic link for migraine?
38. Does chronic daily headache arise de novo in association with regular analgesic use?
39. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside attacks
40. Neuropeptides in the cerebral circulation: Relevance to headache
41. Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists
42. Pharmacological profile of BIBN-, 2000; 4096BS: The first selective small molecule CGRP antagonist
43. Revision of the International Headache Classification. An interim report